4-(Dimethylamino)-2-{2-[(1E)-(methoxyimino)methyl]-1H-pyrrol-1-yl}pyridine-3-carbonitrile

Catalog No. :
ACCPBK315
CAS No. :
303986-38-1
Molecular Formula :
C14H15N5O
Molecular Weight :
269.31

IUPAC Name:(E)-4-(dimethylamino)-2-(2-((methoxyimino)methyl)-1H-pyrrol-1-yl)nicotinonitrile

4-(Dimethylamino)-2-{2-[(1E)-(methoxyimino)methyl]-1H-pyrrol-1-yl}pyridine-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$563.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Dimethylamino)-2-{2-[(1E)-(methoxyimino)methyl]-1H-pyrrol-1-yl}pyridine-3-carbonitrile
IUPAC Name(E)-4-(dimethylamino)-2-(2-((methoxyimino)methyl)-1H-pyrrol-1-yl)nicotinonitrile
Molecular FormulaC14H15N5O
Molecular Weight269.31
SMILESN#CC1=C(N(C)C)C=CN=C1N2C(/C=N/OC)=CC=C2
InChI KeyGFCIJDGYAYUZMD-LICLKQGHSA-N
Synonym4-(DIMETHYLAMINO)-2-(2-[(METHOXYIMINO)METHYL]-1H-PYRROL-1-YL)NICOTINONITRILE;3-Pyridinecarbonitrile, 4-(dimethylamino)-2-[2-[(methoxyimino)methyl]-1H-pyrrol-1-yl]-
CAS No.303986-38-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCPBK315 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCPBK315 route product structure diagram
    ACCPBK315303986-38-1
Inquiry

2. ACCPBK315 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCPBK315 route product structure diagram
    ACCPBK315303986-38-1
Inquiry

Comments (0)